NUTRITION, INFLAMMATION, AND DISEASE
NUTRITION, INFLAMMATION, AND DISEASE
Inflammation has been recognized as an
indicator of illness and injury for thousands of years. References to the
physical symptoms of inflammation—“rubber” (redness), “color” (heat), “tumor” (swelling), and “dolor”
(pain)—date back to a medical treatise written in the first century AD by the
scholar Celsus.
In 1908, the Nobel Prize in medicine was
awarded to scientists Elie Metchnikoff and Paul Ehrlich for their work
outlining the pathogenesis of inflammation.
In more recent years, the inflammation’s
role as a risk factor for various chronic illnesses, including cardiovascular
disease, cancer, and diabetes, has been studied and described. Recognizing the
role of the inflammatory process in disease development has been accompanied by
efforts to identify dietary factors that may promote or inhibit the
inflammatory process, thereby affecting
disease risk and severity.
This continuing education course
explores the mechanisms involved in the inflammatory response, outlines the
role of chronic inflammation in disease development, and summarizes the research investigating the influences
of foods and nutrients in both promoting and inhibiting inflammation.
Types
of Inflammation
Inflammation is characterized as acute
or chronic. Acute inflammation is a normal and comparatively short-lived
physiologic response (lasting minutes to days) to injury, irritation,
or infection. The physiologic processes
responsible for acute inflammation (increased blood flow, greater blood vessel
permeability, and accumulation of white blood cells) lead to redness, swelling,
heat, and pain at the affected site.
Physical symptoms are accompanied by the
generation of new cells and synthesis of the collagen matrix, processes that
promote healing of the damaged tissue.
Chronic inflammation is a long-term
physiologic response (lasting weeks, months, or years) to one or more factors, including
exposure to environmental toxins, a microbial or viral infection, poor nutrition, stress,
and processes related to aging. Chronic inflammation is activated when the
mechanisms of acute inflammation fail to arrest infection or heal an injury.
When unchecked, prolonged chronic
inflammation generates a series of destructive reactions that damage cells and
eventually lead to the clinical symptoms of disease. Ultimately, chronic
inflammation is a failure of the body’s
immune system to maintain a healthy homeostatic state.
Types
of Immunity
The human immune system provides two
types of immunity that interact to defend the body against injury and
infection: innate and adaptive.
Innate immunity, an immediate response
to localized injury or invasion by an infectious agent, is the body’s first
line of defense.
Innate immunity is triggered when a
large sensor protein produced by bone marrow—an inflammasome—detects a toxic substance
and stimulates defensive white cells known as macrophages to attack harmful
cells.7 Macrophages recognize and react to the features of many different types
of pathogens and can engulf harmful cells and initiate the phagocytosis
process.
Macrophages also synthesize regulatory
proteins known as toll receptors that activate various mechanisms in the inflammatory
process, including the production of “natural killer” lymphocytes; nuclear factor-kappa
B (NF-kB), a transcription factor that regulates immune response; and cytokines,
which are proteins involved in cell signaling.
Innate immunity has limited duration and
potency; when overtaxed, the body’s innate immune system triggers the more powerful
activity of adaptive immunity.
Adaptive immunity, sometimes referred to
as acquired immunity, occurs when innate immunity fails to combat infection or
injury. The mechanisms of adaptive immunity are rooted in highly specialized
responses to specific antigens.
There are two types of adaptive
immunity: humoral immunity, in which B lymphocytes, produced by thebone marrow,
create antibodies in response to the presence of antigens; and cellmediated immunity,
in which T lymphocytes, generated by the spleen and lymph nodes, recognize
peptide fragments on the surface of antigen cells that may escape detection by
B lymphocytes.
Both B and T lymphocytes can divide and
develop into effector cells, which detect and destroy infected cells. Unlike the
innate immune system, the adaptive immune system produces memory cells that
recognize and react to repeated exposures to specific antigens.
The systems of innate and adaptive
immunity work together to fight infection and protect the body from disease.
The following is a simplified explanation of their interaction10:
• A toxin, irritant, or microbe invades
the protective epithelium of a tissue, generating the defense mechanisms of the
innate immune system.
• Macrophages produced by the innate
immune system detect and bind pathogens, causing T and B lymphocytes to be
activated and develop into effector cells. Lymphocyte activation marks the initiation
of the adaptive immune system’s processes.
• Effector cells, consisting of lymphocytes,
natural killer cells, and T helper cells (a subclass of lymphocytes), work together
to remove antigens and destroy damaged cells.
Inflammation
and Disease
If the mechanisms of innate and adaptive
immunity ineffectively combat an infection, prolonged inflammation can result
in illness. The progression of chronic inflammation to disease is a complex
process involving many different biological pathways.
Repeated or uncontrolled inflammatory
processes unleash a host of defensive responses, including leukocyte
proliferation, angiogenesis, oxidative reactions, and tissue fibrosis, that
ultimately disturb the normal function of cells and set the stage for disease
development.
Inflammatory
Processes
The development of a specific disease
depends on the site of the inflammatory response. For example, disruption of
the action of glomerular epithelial cells in the kidney results in renal
disease, whereas damage to intestinal enterocytes leads to inflammatory bowel
disease (IBD). Although the underlying factors that trigger different diseases
may vary, the pathology
linking chronic inflammation and disease
onset is marked by the same processes.
Accelerated Cytokine Production
Cytokines are small peptides that act as
signaling systems within the body and affect many biological processes. Because
they facilitate communication between the innate and adaptive
immune systems, cytokines are a key
factor in fighting infection and maintaining homeostasis.
Proinflammatory cytokines such as
interleukin 1 (IL-1) and tumor necrosis factor alpha (TNF-alpha) are released
defensively in response to infection and trauma. Anti-inflammatory
cytokines such as transforming growth
factor beta (TGF-beta) and IL-10 oppose the action of the proinflammatory
cytokines and promote healing.
Elevated plasma levels of
proinflammatory cytokines are biomarkers of inflammation and/or disease. An imbalance
between the activity of proinflammatory and anti-inflammatory cytokines is believed
to affect disease onset, course, and duration.
Blood Concentration of Acute Phase Reactants
The release of cytokines into the
bloodstream signals the liver to produce a variety of proteins known as acute
phase reactants (APRs) that respond to trauma or infection and serve as
biomarkers of inflammation. During chronic inflammation, plasma concentrations
of APRs either increase (positive APRs) or decrease (negative APRs) by at least
25% and sometimes
by as much as 1,000%. Examples of
positive APRs include C-reactive protein (CRP) and serum amyloid A (SAA), while
negative APRs include albumin and transferrin.1
Stimulation of Inflammatory Signaling
Pathways
Cell signaling pathways are the body’s
primary means of communication, directing and regulating all cellular
activities.
The body orchestrates a wide variety of these
signaling pathways that often control more than one activity and engage in communication
(crosstalk) with each other. For example, the
cyclic adenosine monophosphate pathway
responds to the effects of many hormones and neurotransmitters and helps regulate
numerous biological processes, including glycogenolysis, lipogenesis,
lipolysis, and neurotransmitter activity. The NF-kB signaling pathway is an
example of a proinflammatory signaling pathway that drives macrophages and
neutrophils to respond to pathogens.
Inflammatory
Biomarkers in Disease
Obesity
Obesity is associated with an increased
risk of many chronic disorders, including cardiovascular disease, diabetes, hypertension,
metabolic syndrome, and nonalcoholic fatty
liver disease, as well as numerous
cancers (eg, colorectal, gastric, esophageal, pancreatic, breast, endometrial, ovarian).
In particular, abdominal obesity is
associated with chronic low-grade inflammation, which appears to be an adaptive
response to overfeeding.
Adipose tissue is metabolically active
and produces a variety of bioactive molecules called adipokines, which include
hormones, proteins, growth factors, cytokines, and macrophages.
Adipokines have numerous and far-reaching
biological effects, including the regulation of food intake, energy
expenditure, and glucose and fatty acid metabolism. An increase in abdominal
fat causes adipose cells to grow and change shape, leading to cell necrosis and
the disruption of adipokine activity.
Adipose tissue macrophages respond to
increased fat cell mass by stimulating the secretion of the proinflammatory
cytokines TNF-alpha, IL-6, and IL-1 beta, which in turn signal the
liver to produce CRP and initiate inflammatory
pathway signaling.
Compared with normal-weight individuals,
healthy obese people have higher circulating levels of proinflammatory
cytokines and CRP.
Metabolic Syndrome
Metabolic syndrome, which is recognized
as a risk factor for cardiovascular disease and type 2 diabetes, is defined as the
occurrence of three or more of the following conditions:
abdominal obesity, hyperinsulinemia,
hyperglycemia, hypertension, low levels of HDL cholesterol, and
hypertriglyceridemia.
Like obesity, metabolic syndrome is
marked by chronic inflammation, resulting in high circulating levels of the proinflammatory
cytokines TNF-alpha and IL-6, and elevated
serum CRP levels. Plasma CRP concentrations
of 3 mg/L or higher are believed to be an independent predictor of metabolic
syndrome.
The prolonged chronic inflammation of
metabolic syndrome sets the stage for a feedback loop of worsening insulin
resistance, impaired glucose tolerance, and abnormal lipid levels.
Type 2 Diabetes
Abdominal obesity is believed to be the
source of the chronic inflammation that accompanies type 2 diabetes. Diabetes
is accompanied by increased circulating levels of the proinflammatory cytokines
TNF-alpha and IL-6 as well as decreased levels of the anti-inflammatory
cytokine IL-10. Plasma levels of the acute phase reactants SAA and CRP also are
elevated.
In addition, there are increased levels
of fibrinogen, the protein involved in blood clotting, and higher levels of
clotting factors VII and VIII. The net effect of these actions is
hyperglycemia, increased insulin resistance, a higher risk of thrombosis, and abnormal
lipoprotein metabolism.
Atherosclerosis
Atherosclerosis once was believed to
result simply from lipid accumulation in arterial walls. It’s now known that
inflammatory processes are the driving force behind atherosclerotic
plaque development.
Cardiovascular risk factors such as
cigarette smoking, hypertension, and diets rich in trans fat stimulate
endothelial cells within the artery to release a sticky protein called the vascular
cell adhesion molecule, which causes leukocytes to bind to the arterial intima.
The continued depositing of white blood cells onto arterial cell walls
stimulates the release of proinflammatory cytokines, which in turn cause
macrophages called foam cells to engulf lipid fragments, leading to plaque formation
and arterial damage. As damage to the arterial wall
progresses, the cycle of inflammatory
response intensifies, resulting in plaque instability and increasing the risk
of aneurysm, stroke, or heart attack.
Cancer
Chronic inflammation, infection, and
tissue damage are associated with an increased risk of many types of cancer.
Consider the following:
• Inflammatory diseases such as IBD,
Crohn’s disease, and ulcerative colitis are associated with an increased risk
of colon cancer.
• Chronic inflammatory conditions such
as pancreatitis and Barret’s metaplasia are linked with pancreatic and
esophageal cancer, respectively.
• Inflammation resulting from microbial
infection may lead to cancer of the affected organ. For example, chronic infection
with the human papilloma virus or hepatitis B or C virus may result in cervical
and liver cancer, respectively, whereas Helicobacter pylori infection is
a strong predictor of stomach cancer.
• Inflammation arising from exposure to
toxic agents such as asbestos and cigarette smoke is linked with increased risk
of mesothelioma and lung cancer, respectively.
During the normal healing process,
macrophages help fight infection, repair damaged cells, and restore
homeostasis. However, macrophages’ uncontrolled activity during chronic
inflammation is strongly implicated as having a causal role in cancer development.
Highly reactive oxygen and nitrogen
molecules released by macrophages during the healing process may produce harmful
substances that lead to DNA mutation. Proinflammatory
cytokines such as IL-1 and TNF-alpha
block DNA repair and promote tumor growth and metastasis.
Rheumatoid Arthritis
Rheumatoid arthritis is an autoimmune
disease marked by unrestrained growth of the synovial tissue of the joints,
which leads to inflammation, pain, and joint damage. It develops when
proteoglycans, structural proteins found
in cartilage, act as antigens and stimulate T cells to produce various
proinflammatory cytokines, such as TNF-alpha and IL-4, -5, and -6.
The production of these cytokines leads
to joint swelling, pain, and eventual joint destruction. In addition, T
lymphocytes promote the activity of macrophages and B lymphocytes, which
intensify the inflammatory response and hasten joint damage.
Nutrition
and Inflammation
Nutrients play a key role in both
promoting and combating inflammatory processes. Evidence linking nutrients with
inflammatory processes comes from laboratory, clinical, and epidemiologic
studies.
Proinflammatory Nutrients
• Excess calorie intake: Excessive energy intake
stimulates adipose cell growth and proliferation, and promotes abdominal obesity,
thereby increasing the risk of diabetes, metabolic
syndrome, and other chronic diseases. Data
obtained from studies of individuals enrolled in the Calorie Restriction Society,
whose members voluntarily observe calorie-controlled diets as a route to
increased longevity, showed that consuming approximately 1,800 kcal/day (an
approximately 30% reduction from
baseline) over several years decreased serum levels of CRP, TNF-alpha,
proinflammatory growth factors, and body fat, improved BMI, glucose tolerance, insulin
sensitivity, and lipoprotein profiles. These findings were duplicated in
randomized, controlled clinical trials in which lean and obese subjects consumed
20% to 25% fewer calories for periods of six to 12 months.
• Dietary carbohydrate excess: Carbohydrate intake has been
linked to chronic diseases such as obesity, metabolic syndrome, and type 2
diabetes. Of particular interest are foods low
in fiber and rich in sugars and
starches, and those that produce a high glycemic value based on the glycemic
index (GI) scale.
A prospective study conducted in
Australia among postmenopausal women demonstrated that the risk of death from inflammatory
disease, including digestive, respiratory, nervous system, and endocrine disorders,
was nearly three times greater among women consuming a high-GI diet compared
with women eating a low-GI diet. In addition, levels of NF-kB were three times
higher among lean subjects consuming high-GI meals.21 High-GI diets rich in refined
carbohydrate may stimulate proinflammatory IL-6 production and push the liver
to generate
CRP, according to one study.
• Trans fatty acids: Consuming trans fatty acids
is a known risk factor for sudden cardiac death. A possible mechanism suggests that
trans fatty acids induce an inflammatory response in cardiac tissue through
their effect on cell membranes.
Data from an in vitro study published in
the British Journal of Nutrition showed that trans 18:2 fatty acids were
integrated into human aortic endothelial at twice the rate as cis 18:2
fatty
acids, causing the cells to clump
together and bind to arterial walls, stimulating the release of proinflammatory
cytokines.
In addition, studies of patients with
chronic heart failure have demonstrated significant associations between the
trans fatty acid level of red blood cell membranes and plasma biomarkers of
inflammation, including IL-1, IL-6, and TNF-alpha.
• Saturated fatty acids: In vitro studies have shown
that saturated fatty acids play a role in the inflammatory process by
stimulating macrophage production and the secretion of the proinflammatory
cytokines TNF-alpha, IL-6, and IL-8.24 In mice, a diet containing 12% saturated
fat (comparable with the level contained in the average American diet) resulted
in increased body fat and elevated levels of proinflammatory cytokines.25
• Omega-6 polyunsaturated fatty acids: During the last several
decades, the consumption of oils rich in the omega-6 fatty acid linoleic acid
(eg, soybean, corn, safflower, sunflower)
steadily has risen in the United States,
resulting in an increased ratio of omega-6 to omega-3 fatty acids in the
American diet. Ideal dietary levels of omega-6 to omega-3 fatty acids are
believed to be 1 to 4:1; however, the typical American diet now provides a
ratio of about 10:1 to 20:1. This change has been associated with an increased
risk of chronic inflammatory diseases, including atherosclerosis and cardiovascular
disease, rheumatoid arthritis, and IBD.
Omega-6 fatty acids are precursors to
proinflammatory eicosanoids, signaling molecules that help regulate immune function
and are active in the inflammatory process. Linoleic acid (C18:2n-6) is
converted in the liver to the long-chain fatty acid arachadonic acid (C20:4n-6),
which in turn is converted to three types of eicosanoids: prostaglandins,
thromboxanes, and
leukotrienes. These molecules have
potent negative effects on platelet aggregation, blood pressure, and immune
system function and trigger proinflammatory cytokine production.
Anti-Inflammatory Nutrients
• Omega-3 polyunsaturated fatty acids: The omega-3 fatty acids EPA
and DHA, found in fatty fish and fish oil supplements, suppress the production
of proinflammatory eicosanoids and
stimulate the synthesis of anti-inflammatory
eicosanoids (lipoxins) from arachadonic acid. Omega-3 fatty acids also reduce
the generation of the proinflammatory cytokines TNF-alpha, IL-1 beta, IL-6, and
IL-8. In addition, EPA and DHA can be converted to compounds known as resolvins,
which inhibit proinflammatory signaling.
Fish oil supplementation in a dosage of
4 g/day for a minimum of six weeks resulted in significantly decreased plasma levels
of TNF-alpha among individuals with type 2 diabetes and reduced cellular
content of proinflammatory cytokines IL-1 beta, IL-6, and IL-8 in healthy
subjects.
In addition, rheumatoid arthritis
symptom relief was reported in several studies of individuals taking 2 to 4
g/day of supplemental fish oil for periods of three to six months.
Although most studies have focused on
the effects of fish oil, consuming approximately 3 oz of fatty fish (eg, salmon,
herring) five times per week for eight weeks resulted in significant lowering
of plasma levels of proinflammatory cytokines TNFalpha and IL-6 among elderly
Chinese women with dyslipidemia.
Chia seed, walnuts, canola oil, and
flaxseed oil are sources of the omega-3 fatty acid alphalinolenic acid (ALA).
Although ALA has shown some promise in counteracting inflammatory processes,
EPA and DHA appear to be substantially more effective in their
anti-inflammatory effects.
• Ascorbic acid: A powerful antioxidant,
ascorbic acid (vitamin C) defends cells against lipid peroxidation and
scavenges reactive oxygen and nitrogen species such as hydroxyl, peroxyl,
superoxide, nitroxide radical, and
peroxynitrite. Ascorbic acid supports phagocytosis by macrophages and
stimulates the activity of natural killer lymphocytes generated during the
innate immune response. Through its
function as a cofactor in enzymes controlling collagen synthesis, vitamin C
also reduces tissue damage at inflammation sites.
Consuming approximately 70 mg/day of
vitamin C from vegetable soup significantly reduced plasma levels of proinflammatory
prostaglandins and CRP in a small clinical study of healthy subjects. Plasma
vitamin C levels were inversely correlated with symptoms in a prospective study
of the effects of the Mediterranean diet on rheumatoid arthritis, while
supplementation with 1 g/day of vitamin C decreased measures of oxidative
stress and improved endothelial
function in a clinical study of
individuals with hypertension.
In addition, dietary intakes of vitamin
C, as measured by sevenday food records, were negatively associated with plasma
levels of proinflammatory CRP and IL-6 in the Uppsala
Longitudinal Study of Adult Men
published in 2009.29
• Vitamin E: Vitamin E exists in nature as different
chemical structures; the most common forms in the diet are alpha- and gamma tocopherol.
Foods such as seeds, nuts, and vegetable
oils are sources of gamma-tocopherol,
while supplements commonly contain alpha tocopherol.
Alpha- and gamma-tocopherol have
different biological activities. Alpha-tocopherol has long been recognized for
its capacity to scavenge free radicals and prevent lipid oxidation.
In addition, it inhibits the release of
proinflammatory cytokines and reduces CRP levels. Gamma-tocopherol decreases
proinflammatory NF-kB and TNF-alpha activity, and inhibits prostaglandin synthesis.
Dietary intakes of alpha-tocopherol were
inversely related to plasma levels of proinflammatory CRP and IL-6 in the Uppsala
Longitudinal Study of Adult Men.29 However, clinical studies examining vitamin
E intake and measures of inflammation have provided mixed results.
There are several possible explanations
for this.
Most clinical trials assessing the
anti-inflammatory effects of vitamin E primarily have looked at alpha-tocopherol
supplementation and not tocopherols from foods. Alpha-tocopherol
significantly decreases circulating
levels of gamma-tocopherol, decreasing its anti-inflammatory properties.
In addition, alpha- and gamma-tocopherol
may have a synergistic effect on inflammation.3 This finding was observed in a randomized
double-blind trial involving subjects with metabolic syndrome, in which
supplementation with 800 mg/day of a combination of alpha- and gamma-tocopherol
was more effective in reducing plasma CRP and TNF-alpha levels than were either
supplement alone.
Vitamin E shows some promise in the
treatment of rheumatoid arthritis symptoms. A clinical study demonstrated a
significant reduction in joint stiffness and pain following twice-daily
supplementation with 600 mg of
alpha-tocopherol, although plasma inflammatory biomarkers weren’t changed.
• Polyphenols: These aromatic compounds are
found in fruits, vegetables, grains, chocolate, coffee, olive oil, and tea. To date,
thousands of polyphenols have been identified and classified into different
subgroups.31 Two such groups are flavonoids and lignans.
Flavonoids include the flavanones
naringenin and hesperidin (found in citrus fruit); flavonols such as myricetin,
kaempferol, and quercetin (found in apples, cocoa, and onions); and the
flavones luteolin and apigenin (found in celery), catechins (found in tea), and
anthocyanins (found in berries). Phenolic acids (caffeic acid, gallic acid, and
ferulic acid) are found in coffee, olive oil, tea, grains, peanuts, and
berries.
Lignans (secoisolariciresinol and
matairesinol) are found primarily in flaxseeds.
The polyphenol resveratrol, classified
as a stilbenoid, is found in red wine and berries.
Many polyphenols show powerful anti-inflammatory
effects. Laboratory investigations, clinical trials, and prospective studies suggest
that polyphenols inhibit enzymes involved in prostaglandin and leukotriene synthesis,
prevent free radical formation, decrease proinflammatory cytokine production,
and block the activity of proinflammatory signaling
systems.31-33 However, the effect of dietary
polyphenols on human inflammatory
biomarkers requires further study
because of wide variation in the polyphenol content
of foods, differences in postprandial
plasma concentrations, and inadequate knowledge
of tissue stores.
• Prebiotics and probiotics: Prebiotics are defined as
nondigestible, nonabsorbable substances that can be fermented by bacteria in
the gut, promote the growth of desirable microflora, and impart improvements to
health. Prebiotics include oligofructose, a short-chain fructose polymer, and
inulin, a type of dietary fiber. Food sources of prebiotics include chicory,
Jerusalem artichokes, and onions. Inulin is an additive in many commercially
prepared foods and sold as a dietary supplement.
The World Health Organization defines probiotics
as “live microorganisms, which,
when administered in adequate amounts, confer
a health benefit to the host.” Probiotics
are bacteria that are classified
primarily as either lactobacillus or bifidobacteria; both
are part of the normal gut flora and can
ferment lactose. They’re found in cultured dairy
foods such as yogurt and kefir and also
are available in supplement form.
Animal studies have shown that both prebiotics
and probiotics can decrease the activity of proinflammatory cytokines and
NF-kB, and increase levels of antiinflammatory
TGF-beta within the gut mucosa. Both
prebiotics and probiotics appear to interact directly with gut epithelium cells
to block pathogens from entering.
Clinical trials have helped corroborate the
anti-inflammatory effects of prebiotics seen in laboratory studies. Infants and
children with diarrheal illness showed marked improvement in symptoms (eg,
decreased diarrhea, vomiting, fever) when given supplemental
inulin. Administered to patients with
ulcerative colitis or precancerous colon
polyps, inulin improved measures of
disease activity and reduced levels of intestinal proinflammatory proteins.
Studies investigating the efficacy of supplemental
probiotics in alleviating inflammatory activity in Crohn’s disease and ulcerative
colitis have looked at both single strains of bacteria, such as Lactobacillus
acidophilus, as well as mixtures of bacteria, such as Streptococcus thermophiles
and Bifidobacterium bifidum. The results have been mixed but generally
support a role for probiotics in decreasing disease activity and improving clinical
symptoms. In addition, consuming cultured dairy foods has been found to alleviate
symptoms of IBD, ulcerative colitis, and pouchitis.
Anti-Inflammatory
Foods and Dietary Patterns
Various foods and dietary patterns are
effective in reducing the underlying inflammatory processes associated with chronic
disease.
A diet high in fruits and vegetables may
be one of the best defenses against chronic inflammation. Fruits and vegetables
are a highly bioavailable source of vitamins, minerals, fiber, and polyphenols
with anti-inflammatory activity. A cross-sectional study investigating self-reported
fruit and vegetable intake among adults found that individuals reporting the
highest consumption (more than two servings of fruit and three servings of vegetables
daily) had significantly lower plasma levels of proinflammatory CRP, IL-6, and TNF-alpha
as well as decreased biomarkers of oxidative stress. Four to five servings
daily each of fruits and vegetables are recommended to combat inflammation and
chronic disease.
The Mediterranean diet is characterized
by the generous consumption of vegetables, fruits, grains, legumes, and nuts; a
minimal intake of red meat and whole-fat dairy products;
increased fish consumption; moderate red
wine intake; and liberal use of olive oil in cooking and food preparation.
Compared with Western diets, the Mediterranean diet is rich in fiber, polyphenols,
antioxidants, and omega-3 fatty acids and low in saturated fat and refined
carbohydrate. Data from epidemiologic and clinical studies have demonstrated that
consuming a Mediterranean- type diet reduces plasma levels of proinflammatory
biomarkers, including endothelial
adhesion molecules, CRP, TNF-alpha, and NF-kB.
High-fiber, low-GI foods appear to have
a beneficial effect on inflammatory biomarkers. Adhering to a low-GI diet for
one year resulted in significantly lower plasma levels of CRP in a clinical
randomized trial of subjects with type 2 diabetes compared with adhering to
high-GI and low-carbohydrate diets.
The low-GI diet consisted of high-fiber
breakfast cereals, whole grains, and legumes, and provided 52% carbohydrate, an
average GI of 55, and 36 g of fiber per day. In contrast, the high-GI diet
containing refined cereals, white bread, and potatoes supplied 47%
carbohydrate, an average GI of 63, and 21 g of fiber per day; and the
low-carbohydrate diet containing nuts, avocados, and olives, provided 39% carbohydrate,
an average GI of 59, and 23 g of fiber per day.
Whole grain foods consist of the
unaltered grain with intact bran and germ components, which are valuable sources
of fiber, phytochemicals, vitamins, and minerals. Prospective and clinical
studies have suggested that consuming whole grain foods such as oats, barley, and
brown rice may help decrease inflammation associated with metabolic syndrome,
diabetes,
and cardiovascular disease.
Weight loss is known to have beneficial
effects on metabolic syndrome, type 2 diabetes, and other chronic conditions.
A small clinical study found that obese
individuals who lost 10% or more of their body weight on a low-calorie liquid
diet regimen significantly had reduced plasma levels of proinflammatory macrophage
proteins and proinflammatory cytokines IL-6, -15, and -18. The greatest
reductions were seen among subjects achieving a weight loss of 14% or more,
suggesting that decreased caloric consumption has a beneficial effect on
inflammation independent of nutrient intake.
Future
Directions
Evidence supporting the diet’s role both
in promoting and hindering inflammatory processes is mounting. Additional research
is needed to identify the independent and interactive effects of foods and
nutrients and to evaluate the protective role of supplements in fighting inflammation.
Clinical
Recommendations
There are many simple dietary strategies
that may effectively reduce levels of chronic inflammation and decrease disease
risk. However, individuals with chronic disease often feel overwhelmed by the
many lifestyle changes they’re asked to make. In addition, they may be unaware
of the role diet plays in affecting the inflammatory processes underlying many
chronic illnesses.
Dietitians can support their clients and
patients by emphasizing dietary changes that will help reduce inflammation levels
in the body and begin to restore normal immune function.
Encouraging clients to increase their
intake of fruits, vegetables, whole grains, nuts, olive oil, and fatty fish is
a positive message that can accompany advice to reduce their consumption
of refined starches and sweets, and
foods laden with trans and saturated fat.
It’s important for dietitians to stress
that anti-inflammatory benefits are derived from the synergistic effect of
foods eaten together as well as from individual foods and that seemingly
small changes can play a major role in
improving health.
Focusing on personalized goals and
setting achievable objectives (eg, eat an extra serving of fruit at lunch) is
key to helping clients make lasting dietary changes that will combat
inflammation and enhance overall health.
10 WAYS FOODS CAN REDUCE INFLAMMATION
Many people with diabetes, high cholesterol, hypertension, and other chronic
health problems have high levels of inflammation in their bodies that occur
over time when the immune system tries unsuccessfully to repair cells and rid
itself of harmful toxins. The right foods can help reduce the amount of
inflammation in the body and improve health. Here are 10 suggestions for
clients and patients for eating to decrease inflammation:
1. Boost consumption of fruits and vegetables. Aim to eat four to
five servings each of fruits and vegetables daily. Choose fruits and vegetables
that are deep green, orange, yellow, and purple, since these have the greatest nutritional
value. Ten servings per day may sound like too much, but serving sizes are
small: one medium fruit, 1⁄2 cup canned or frozen fruit, 1⁄2 cup cooked
vegetable, 1⁄2 cup fruit juice, and 1 cup leafy raw greens.
2. Cook with olive oil as much as possible and use it to make
salad dressings. Make a quick and easy dressing by combining 3⁄4 cup olive oil,
1⁄4 cup balsamic vinegar, 1⁄2 clove minced garlic, and 1 T each of chopped
fresh parsley and chives. (Use 1⁄2 tsp dried herbs if fresh herbs aren’t
available.) Virgin olive oil is best since it has more inflammation-fighting
antioxidants than refined olive oil.
3. Snack on walnuts instead of chips. Walnuts provide fiber,
minerals, antioxidants, and the kinds of fatty acids that are good for your
heart.
4. Eat a whole grain cereal such as oatmeal for breakfast, and
replace refined grains with whole grains, such as substituting brown rice for
white rice.
5. Eat fatty fish such as salmon two to three times per week to
get more omega-3 fatty acids. Wild salmon has more omega-3s than farmed salmon.
6. Eat fewer fast foods. Many tend to be cooked in oils that
contain trans fatty acids, which increase inflammation. If you eat at fast-food
restaurants, order a grilled chicken sandwich or salad with vinaigrette
dressing.
7. Replace white potatoes with sweet potatoes. They’re high in
vitamins and delicious when baked with a little olive oil, garlic, and
rosemary.
8. Cut down on sugary drinks such as juice, soda, and punch. Add
small amounts of cider, fruit juice, or wedges of lemon or orange to plain
water to enhance the flavor.
9. Eat more lentils and beans. They’re good sources of protein
and can replace red meat at meals. Try black beans and brown rice sautéed with onions
and garlic and seasoned with cumin.
10. Munch on dark chocolate and fresh raspberries for dessert.
Both are loaded with antioxidants.
All Fitness __ NUTRITION, INFLAMMATION, AND DISEASE
Mary Franz, MS, RDN, LDN, is
a research dietitian at Harvard University and a freelance health and science
writer.
No comments